journal
Journals Journal of Clinical Endocrinol...

Journal of Clinical Endocrinology and Metabolism

https://read.qxmd.com/read/38717942/cardiovascular-safety-and-romosozumab-the-plot-thickens
#1
EDITORIAL
Joshua N Farr
No abstract text is available yet for this article.
May 8, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38717911/exome-sequencing-has-a-high-diagnostic-rate-in-sporadic-congenital-hypopituitarism-and-reveals-novel-candidate-genes
#2
JOURNAL ARTICLE
Julian Martinez-Mayer, Sebastian Vishnopolska, Catalina Perticarari, Lucia Iglesias Garcia, Martina Hackbartt, Marcela Martinez, Jonathan Zaiat, Andrea Jacome-Alvarado, Debora Braslavsky, Ana Keselman, Ignacio Bergadá, Roxana Marino, Pablo Ramírez, Natalia Pérez Garrido, Marta Ciaccio, Maria Isabel Di Palma, Alicia Belgorosky, Maria Veronica Forclaz, Gabriela Benzrihen, Silvia D'Amato, Maria Lujan Cirigliano, Mirta Miras, Alejandra Paez Nuñez, Laura Castro, Maria Susana Mallea-Gil, Carolina Ballarino, Laura Latorre-Villacorta, Ana Clara Casiello, Claudia Hernandez, Veronica Figueroa, Guillermo Alonso, Analia Morin, Zelmira Guntsche, Hane Lee, Eugene Lee, Yongjun Song, Marcelo Adrian Marti, Maria Ines Perez-Millan
CONTEXT: The pituitary gland is key for childhood growth, puberty, and metabolism. Pituitary dysfunction is associated with a spectrum of phenotypes, from mild to severe. Congenital Hypopituitarism (CH) is the most commonly reported pediatric endocrine dysfunction with an incidence of 1:4000, yet low rates of genetic diagnosis have been reported. OBJECTIVE: We aimed to unveil the genetic etiology of CH in a large cohort of patients from Argentina. METHODS: We performed whole exome sequencing of 137 unrelated cases of CH, the largest cohort examined with this method to date...
May 8, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38717898/moderate-associations-between-the-use-of-levonorgestrel-releasing-intrauterine-device-and-metabolomics-profile
#3
JOURNAL ARTICLE
Elena Toffol, Oskari Heikinheimo, Pekka Jousilahti, Lara Lehtoranta, Anni Joensuu, Timo Partonen, Iris Erlund, Jari Haukka
CONTEXT: Use of levonorgestrel-releasing intrauterine device (LNG-IUD) has become common irrespective of age and parity. To date, only a few studies have examined its possible metabolic changes and large-scale biomarker profiles in detail and in a longitudinal design. OBJECTIVE: To apply the metabolomics technique to examine the metabolic profile associated with the use of LNG-IUD both in a cross-sectional and in a longitudinal design. DESIGN: The study consists of cross-sectional and longitudinal analyses of a population-based survey (Health 2000) and its 11-year follow-up (Health 2011)...
May 8, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38717871/testosterone-therapy-does-not-affect-coagulation-in-male-hypogonadism-a-longitudinal-study-based-on-thrombin-generation
#4
JOURNAL ARTICLE
Valeria Lanzi, Rita Indirli, Armando Tripodi, Marigrazia Clerici, Marco Bonomi, Biagio Cangiano, Iulia Petria, Maura Arosio, Giovanna Mantovani, Emanuele Ferrante
CONTEXT: Testosterone therapy has been variably associated with increased thrombotic risk but investigations of global coagulation in this setting are lacking. OBJECTIVE: To compare global coagulation of hypogonadal men before (T0) and 6 months after (T1) starting testosterone replacement therapy (TRT), and healthy controls. DESIGN: Observational prospective cohort study. SETTING: Two tertiary endocrinological ambulatory care centers...
May 8, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38712435/letter-to-the-editor-from-bala-and-dayal-safety-and-efficacy-of-denosumab-in-children-with-osteogenesis-imperfecta-the-first-prospective-comparative-study
#5
JOURNAL ARTICLE
Anju Bala, Devi Dayal
No abstract text is available yet for this article.
May 7, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38712430/response-to-letter-to-the-editor-from-bala-and-dayal-safety-and-efficacy-of-denosumab-in-children-with-osteogenesis-imperfecta-the-first-prospective-comparative-study
#6
JOURNAL ARTICLE
Jiayi Liu, Mei Li
No abstract text is available yet for this article.
May 7, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38712386/beyond-stages-predicting-individual-time-dependent-risk-for-type-1-diabetes
#7
JOURNAL ARTICLE
Stephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez, Megan Smithmyer, Christine Bender, Cate Speake, Sandra Lord, Carla J Greenbaum
BACKGROUND: Essentially all individuals with multiple autoantibodies will develop clinical type 1 diabetes. Multiple AABs and normal glucose tolerance define Stage 1 diabetes; abnormal glucose tolerance defines Stage 2. However, the rate of progression within these stages is heterogeneous, necessitating personalized risk calculators to improve clinical implementation. METHODS: We developed 3 models using TrialNet's Pathway to Prevention data to accommodate the reality that not all risk variables are clinically available...
May 7, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38709677/association-between-visceral-obesity-index-and-diabetes-a-systematic-review-and-meta-analysis
#8
JOURNAL ARTICLE
Ruixue Deng, Weijie Chen, Zepeng Zhang, Jingzhou Zhang, Ying Wang, Baichuan Sun, Kai Yin, Jingsi Cao, Xuechun Fan, Yuan Zhang, Huan Liu, Jinxu Fang, Jiamei Song, Bin Yu, Jia Mi, Xiangyan Li
CONTENT: The correlation between visceral obesity index (VAI) and diabetes and accuracy of early prediction of diabetes are still controversial. OBJECTIVE: This study aims to review the relationship between high level of VAI and diabetes, and early predictive value of diabetes. DATA SOURCES: The databases of PubMed, Cochrane, Embase, and Web of Science were searched until October 17, 2023. STUDY SELECTION: After adjusting for confounding factors, the original study on the association between VAI and diabetes was analyzed...
May 6, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38706378/pancreatic-neuroendocrine-tumors-in-french-vhl-mutation-carriers-a-multicentric-retrospective-study
#9
JOURNAL ARTICLE
Marie Muller, Pascal Hammel, Anne Couvelard, Anne-Laure Védie, Jérôme Cros, Nelly Burnichon, Agathe Hercent, Alain Sauvanet, Stéphane Richard, Louis de Mestier
BACKGROUND: Von Hippel-Lindau disease (VHL) is a rare autosomal dominant hereditary cancer-predisposition syndrome caused by germline pathogenic variants (PV) in VHL gene. It is associated with a high penetrance of benign and malignant vascular tumors in multiples organs, including pancreatic neuroendocrine tumors (PanNETs), whose long-term natural history is ill-known. METHODS: Patients with both documented germline PV in VHL gene and PanNETs included in the French PREDIR database between 1995 and 2022 were included...
May 6, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38706369/cahql-a-patient-reported-outcome-instrument-to-assess-health-related-quality-of-life-in-congenital-adrenal-hyperplasia
#10
JOURNAL ARTICLE
Myrto Eleni Flokas, Li Yang, Kimberly R Middleton, Sarah Kollender, Megan Parker, Charles Sukin, Rebecca Wood Persky, Deborah P Merke
CONTEXT: Measuring health-related quality of life (HRQoL) is a crucial aspect of evaluating health care outcomes. Patients with congenital adrenal hyperplasia (CAH) often self-report deficiencies in HRQoL. OBJECTIVE: The aim of our study was to develop a disease-specific patient reported outcome (PRO) instrument to evaluate the HRQoL of patients >16 years old with classic congenital adrenal hyperplasia (CAH). DESIGN, SETTING AND OUTCOMES: Following the FDA guidelines for developing PRO instruments, we developed a conceptual framework for the instrument...
May 6, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38703102/n-terminal-pro-b-type-natriuretic-peptide-and-risk-for-diabetes-mellitus-and-metabolic-syndrome
#11
JOURNAL ARTICLE
Charles D Nicoli, D Leann Long, Timothy B Plante, Suzanne E Judd, Leslie A McClure, April P Carson, Mary Cushman
CONTEXT: Natriuretic peptide concentrations are inversely associated with risk of diabetes mellitus and may be protective from metabolic dysfunction. OBJECTIVE: We studied associations of N-terminal pro-B-type natriuretic peptide (NT-proBNP) with incident diabetes, metabolic syndrome (MetS), and MetS components. DESIGN/SETTING/PARTICIPANTS: 2,899 participants with baseline (2003-2007) and follow-up (2013-2016) examinations and baseline NT-proBNP measurement in the REasons for Geographic And Racial Differences in Stroke study...
May 4, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38703096/associations-of-plasma-and-fecal-metabolites-with-body-mass-index-and-body-fat-distribution-in-children
#12
JOURNAL ARTICLE
Zhen Hong, Kejun Zhou, Yuanhuan Wei, Bingjie Ma, Guoxiang Xie, Zheqing Zhang, Jingjing Liang
CONTEXT: Childhood obesity continues to be a critical public health concern with far-reaching implications for the well-being. OBJECTIVE: This study aimed to investigate the association between metabolites in plasma and feces and indicators including body mass index (BMI), BMI for age Z score (BMIZ), and body fat distribution among children aged 6-9 years in China. METHODS: This cross-sectional study enrolled 424 healthy children, including 186 girls and 238 boys...
May 4, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38703083/risk-of-gestational-diabetes-in-women-with-pcos-based-on-body-mass-index-the-japan-environment-and-children-s-study
#13
JOURNAL ARTICLE
Chihiro Okoshi, Hyo Kyozuka, Toma Fukuda, Shun Yasuda, Tsuyoshi Murata, Hirotaka Isogami, Akiko Sato, Yuka Ogata, Mitsuaki Hosoya, Seiji Yasumura, Koichi Hashimoto, Hidekazu Nishigori, Michihiro Kamijima, Shin Yamazaki, Yukihiro Ohya, Reiko Kishi, Nobuo Yaegashi, Chisato Mori, Shuichi Ito, Zentaro Yamagata, Hidekuni Inadera, Takeo Nakayama, Tomotaka Sobue, Masayuki Shima, Seiji Kageyama, Narufumi Suganuma, Shouichi Ohga, Takahiko Katoh, Keiya Fujimori, Toshifumi Takahashi
CONTEXT: Women with polycystic ovary syndrome (PCOS), which is the most common endocrine disorder in women of reproductive age, have a potentially increased risk of gestational diabetes mellitus (GDM). OBJECTIVE: To examine the impact of PCOS on GDM based on maternal body mass index (BMI) using data from a large birth cohort study in Japan. DESIGN: Prospective observational study using data from the Japan Environment and Children's Study (JECS)...
May 4, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701358/cost-effectiveness-of-genetic-testing-of-endocrine-tumor-patients-using-a-comprehensive-hereditary-cancer-gene-panel
#14
JOURNAL ARTICLE
Attila Patócs, Petra Nagy, János Papp, Anikó Bozsik, Bálint Antal, Vince Kornél Grolmusz, Tímea Pócza, Henriett Butz
INTRODUCTION: Heterogenous clinical manifestations, overlapping phenotypes and complex genetic backgrounds are common in patients with endocrine tumors. There are no comprehensive recommendations for genetic testing and counselling of these patients compared to other hereditary cancer syndromes. The application of multigene panel testing is common in clinical genetic laboratories, but their performance for patients with endocrine tumors has not been assessed. METHODS: As a national reference center, we prospectively tested the diagnostic utility and cost-efficiency of a multigene panel covering 113 genes representing genetic susceptibility for solid tumors...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701346/metabolic-syndrome-and-the-risk-of-kidney-stones-a-large-scale-cohort-study-from-487-860-uk-biobank-participants
#15
JOURNAL ARTICLE
Minghui Liu, Meng Gao, Jian Wu, Zewu Zhu, Jiao Hu, Hequn Chen, Zhiyong Chen, Jinbo Chen
OBJECTIVE: While some studies have suggested an association between metabolic syndrome and kidney stones, the quality and level of evidence in these studies vary. Whether some individual characteristics and clustering of metabolic syndrome traits increase the risk of kidney stones has not been examined in a large-scale prospective cohort. MATERIALS: We conducted a retrospective analysis of data from a prospective cohort of 487,860 UK Biobank participants who were free from kidney stones at baseline...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701341/can-incorporating-molecular-testing-improve-the-accuracy-of-newborn-screening-for-congenital-adrenal-hyperplasia
#16
JOURNAL ARTICLE
Kyriakie Sarafoglou, Amy Gaviglio, Carrie Wolf, Cindy P Lorentz, Aida Lteif, Jennifer Kyllo, Gretchen Radloff, Zachary Detwiler, Carla D Cuthbert, James S Hodges, Scott D Grosse, Christopher N Greene, Suzanne Cordovado
BACKGROUND: Single-tier newborn screening (NBS) for CAH using 17-hydroxyprogesterone (17OHP) measured by fluoroimmunoassay (FIA) in samples collected at 24-48 hours produces a high false-positive rate (FPR). 2nd tier steroid testing can reduce the FPR and has been widely implemented. We investigated the accuracy of an alternative multi-tier CAH NBS protocol that incorporates molecular testing of the CYP21A2 gene and reduces the 1st tier 17OHP cutoff to minimize missed cases. METHODS: Created a Minnesota-specific CYP21A2 pathogenic variants panel; develop a rapid, high-throughput multiplex, allele-specific-primer-extension assay; perform 1-year retrospective analysis of Minnesota NBS results comparing metrics between a conventional steroid-based two-tier protocol and a molecular-based multi-tier NBS protocol, applied post-hoc...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701087/the-influence-of-trinucleotide-repeats-in-the-androgen-receptor-gene-on-androgen-related-traits-and-diseases
#17
JOURNAL ARTICLE
Takayoshi Sasako, Yann Ilboudo, Kevin Y H Liang, Yiheng Chen, Satoshi Yoshiji, J Brent Richards
CONTEXT: Trinucleotide repeats in the androgen receptor have been proposed to influence testosterone signaling in men, but the clinical relevance of these trinucleotide repeats remains controversial. OBJECTIVE: To examine how androgen receptor trinucleotide repeat lengths affect androgen-related traits and disease risks and whether they influence the clinical importance of circulating testosterone levels. METHODS: We quantified CAG and GGC repeat lengths in the androgen receptor (AR) gene of European-ancestry male participants in UK Biobank from whole-genome and whole-exome sequence data using ExpansionHunter, and tested associations with androgen-related traits and diseases...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38700099/thyroid-dysfunction-risk-after-iodinated-contrast-media-administration-a-prospective-longitudinal-cohort-analysis
#18
JOURNAL ARTICLE
Seo Young Sohn, Kosuke Inoue, Muhammad T Bashir, Jesse W Currier, Natalia V Neverova, Ramin Ebrahimi, Connie M Rhee, Martin L Lee, Angela M Leung
CONTEXT: Iodinated contrast media (ICM) is a common source of excess iodine in medical settings, given the common use of iodinated radiologic procedures. OBJECTIVE: To determine the long-term risks of thyroid dysfunction following iodinated contrast administration in a prospective study. DESIGN, SETTING, PARTICIPANTS: A longitudinal cohort study was conducted of patients in the U.S. Veterans Affairs medical system who received ICM. MAIN OUTCOME MEASURES: Serum thyroid function, thyroid antibody, and inflammatory markers were measured at baseline...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38695547/improvement-of-%C3%AE-cell-function-after-switching-from-dpp-4-inhibitors-to-oral-semaglutide-switch-sema2-post-hoc-analysis
#19
JOURNAL ARTICLE
Hiroshi Nomoto, Sho Furusawa, Hiroki Yokoyama, Yuka Suzuki, Rimi Izumihara, Yuki Oe, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, Yoshio Kurihara, Akinobu Nakamura, Tatsuya Atsumi
CONTEXT: Whether continuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) or switching to oral semaglutide is more beneficial for β-cell function is unclear. OBJECTIVE: To assess the efficacy of switching from DPP-4is to oral semaglutide for β-cell function compared with DPP-4i continuation. METHODS: Post hoc analysis of SWITCH-SEMA 2, a multicenter prospective randomized controlled trial on the switch to oral semaglutide vs DPP-4i continuation without dose adjustment for 24 weeks in subjects with type 2 diabetes treated with DPP-4is, was conducted...
May 2, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38693775/risk-assessment-of-diabetes-mellitus-during-and-after-pregnancy-in-women-with-prolactinomas
#20
JOURNAL ARTICLE
Roberta Scairati, Renata S Auriemma, Sara Di Meglio, Guendalina Del Vecchio, Rosa Pirchio, Chiara Graziadio, Claudia Pivonello, Rosario Pivonello, Annamaria Colao
CONTEXT: Prolactin (PRL) is a crucial mediator of gluco-insulinemic metabolism. OBJECTIVE: Dissecting glucose metabolism during and after pregnancy in patients with prolactinomas. METHODS: 52 patients treated with cabergoline (CAB) were evaluated before conception, during pregnancy and up to 10 years after delivery. During pregnancy, CAB was discontinued, while it was restarted in 57.7 % of patients after delivery, due to recurrent hyperprolactinemia (RH)...
May 2, 2024: Journal of Clinical Endocrinology and Metabolism
journal
journal
20145
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.